Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;84:467-474

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doenst, T.
Right arrow Articles by Taegtmeyer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doenst, T.
Right arrow Articles by Taegtmeyer, H.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
(Circulation Research. 1999;84:467-474.)
© 1999 American Heart Association, Inc.


Original Contribution

{alpha}-Adrenergic Stimulation Mediates Glucose Uptake Through Phosphatidylinositol 3-Kinase in Rat Heart

Presented in part at the 70th Annual Scientific Sessions of the American Heart Association, Orlando, Fla, November 9–12, 1997, and published in abstract form (Circulation. 1997;96[suppl I]:I-691).

Torsten Doenst, Heinrich Taegtmeyer

From the Department of Medicine, Division of Cardiology, University of Texas-Houston Medical School, Houston, Tex.

Correspondence to Heinrich Taegtmeyer, MD, DPhil, Department of Internal Medicine, Division of Cardiology, University of Texas-Houston Medical School, 6431 Fannin, MSB 1.246, Houston, TX 77030. E-mail ht{at}heart.med.uth.tmc.edu

Abstract—We examined whether insulin and catecholamines share common pathways for their stimulating effects on glucose uptake. We perfused isolated working rat hearts with Krebs-Henseleit buffer containing [2-3H]glucose (5 mmol/L, 0.05 µCi/mL) and sodium oleate (0.4 mmol/L). In the absence or presence of the phosphatidylinositol 3-kinase (PI3-K) inhibitor wortmannin (3 µmol/L), we added insulin (1 mU/mL), epinephrine (1 µmol/L), phenylephrine (100 µmol/L) plus propranolol (10 µmol/L, selective {alpha}-adrenergic stimulation), or isoproterenol (1 µmol/L) plus phentolamine (10 µmol/L, selective ß-adrenergic stimulation) to the perfusate. Cardiac power was found to be stable in all groups (between 8.07±0.68 and 10.7±0.88 mW) and increased (25% to 47%) with addition of epinephrine, but not with selective {alpha}- and ß-adrenergic stimulation. Insulin and epinephrine, as well as selective {alpha}- and ß-receptor stimulation, increased glucose uptake (the following values are in µmol/[min · g dry weight]: basal, 1.19±0.13; insulin, 3.89±0.36; epinephrine, 3.46±0.27; {alpha}-stimulation, 4.08±0.40; and ß-stimulation, 3.72±0.34). Wortmannin completely inhibited insulin-stimulated and selective {alpha}-stimulated glucose uptake, but it did not affect the epinephrine-stimulated or selective ß-stimulated glucose uptake. Sequential addition of insulin and epinephrine or insulin and {alpha}-selective stimulation showed additive effects on glucose uptake in both cases. Wortmannin further blocked the effects of insulin on glycogen synthesis. We conclude that {alpha}-adrenergic stimulation mediates glucose uptake in rat heart through a PI3-K–dependent pathway. However, the additive effects of {alpha}-adrenergic stimulation and insulin suggest 2 different isoforms of PI3-K, compartmentation of PI3-K, potentiation, or inhibition by wortmannin of another intermediate of the {alpha}-adrenergic signaling cascade. The stimulating effects of both the {alpha}- and the ß-adrenergic pathways on glucose uptake are independent of changes in cardiac performance.


Key Words: isolated working rat heart • wortmannin • glucose tracer • signal transduction




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Doenst, H. Bugger, M. Schwarzer, G. Faerber, M. A. Borger, and F. W. Mohr
Three good reasons for heart surgeons to understand cardiac metabolism
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 862 - 871.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Q. Wu, M. Kazantzis, H. Doege, A. M. Ortegon, B. Tsang, A. Falcon, and A. Stahl
Fatty Acid Transport Protein 1 Is Required for Nonshivering Thermogenesis in Brown Adipose Tissue
Diabetes, December 1, 2006; 55(12): 3229 - 3237.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. S. Hutchinson and T. Bengtsson
{alpha}1A-Adrenoceptors Activate Glucose Uptake in L6 Muscle Cells through a Phospholipase C-, Phosphatidylinositol-3 Kinase-, and Atypical Protein Kinase C-Dependent Pathway
Endocrinology, February 1, 2005; 146(2): 901 - 912.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
U. Fischer-Rasokat and T. Doenst
Insulin-induced improvement of postischemic recovery is abolished by inhibition of protein kinase C in rat heart
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1806 - 1812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. F. Soto, P. Herrero, A. M. Kates, C. S. Dence, A. A. Ehsani, V. Davila-Roman, K. B. Schechtman, and R. J. Gropler
Impact of aging on myocardial metabolic response to dobutamine
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2158 - H2164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. L. Coven, X. Hu, L. Cong, R. Bergeron, G. I. Shulman, D. G. Hardie, and L. H. Young
Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E629 - E636.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Young, P. McNulty, and H. Taegtmeyer
Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms
Circulation, April 16, 2002; 105(15): 1861 - 1870.
[Full Text] [PDF]


Home page
CirculationHome page
H. Taegtmeyer, P. McNulty, and M. E. Young
Adaptation and Maladaptation of the Heart in Diabetes: Part I: General Concepts
Circulation, April 9, 2002; 105(14): 1727 - 1733.
[Full Text] [PDF]


Home page
DiabetesHome page
R. J. Sidell, M. A. Cole, N. J. Draper, M. Desrois, R. E. Buckingham, and K. Clarke
Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart
Diabetes, April 1, 2002; 51(4): 1110 - 1117.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. R. Wallhaus, M. Taylor, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone
Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure
Circulation, May 22, 2001; 103(20): 2441 - 2446.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Salvi
Protecting the Myocardium From Ischemic Injury : A Critical Role for {{alpha}}1-Adrenoreceptors?
Chest, April 1, 2001; 119(4): 1242 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tong, W. Chen, R. E. London, E. Murphy, and C. Steenbergen
Preconditioning Enhanced Glucose Uptake Is Mediated by p38 MAP Kinase Not by Phosphatidylinositol 3-Kinase
J. Biol. Chem., April 14, 2000; 275(16): 11981 - 11986.
[Abstract] [Full Text] [PDF]